Nothing Special   »   [go: up one dir, main page]

FI940224A0 - Ophthalmic compositions containing oxycam or oxycam derivatives - Google Patents

Ophthalmic compositions containing oxycam or oxycam derivatives

Info

Publication number
FI940224A0
FI940224A0 FI940224A FI940224A FI940224A0 FI 940224 A0 FI940224 A0 FI 940224A0 FI 940224 A FI940224 A FI 940224A FI 940224 A FI940224 A FI 940224A FI 940224 A0 FI940224 A0 FI 940224A0
Authority
FI
Finland
Prior art keywords
oxycam
compositions containing
derivatives
ophthalmic compositions
compositions
Prior art date
Application number
FI940224A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI940224A (en
FI107700B (en
Inventor
Gerard Schwadrohn
Original Assignee
Europhta Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Europhta Lab filed Critical Europhta Lab
Publication of FI940224A0 publication Critical patent/FI940224A0/en
Publication of FI940224A publication Critical patent/FI940224A/en
Application granted granted Critical
Publication of FI107700B publication Critical patent/FI107700B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Novel pharmaceutical compositions for ophthalmic use, particularly instillable ophthalmic compositions having average viscosity and characterized in that they contain, as the active principle, an anti-flammatory agent which is optionally combined with an antibacterial agent, a gellable acrylic acid polymer and a basic agent to form a fluid aqueous solute with a pH of 7.0-8.0. The compositions are useful for treating inflammatory diseases of the eyeball.
FI940224A 1991-07-18 1994-01-17 Process for the preparation of ophthalmic compositions FI107700B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9109096A FR2679135B1 (en) 1991-07-18 1991-07-18 NOVEL OPHTHALMIC COMPOSITIONS WITH IMPROVED ADHESIVITY AND METHODS OF PREPARING THE SAME.
FR9109096 1991-07-18
FR9200696 1992-07-17
PCT/FR1992/000696 WO1993001814A1 (en) 1991-07-18 1992-07-17 Oxicam or oxicam derivatives-containing ophthalmic compositions

Publications (3)

Publication Number Publication Date
FI940224A0 true FI940224A0 (en) 1994-01-17
FI940224A FI940224A (en) 1994-03-14
FI107700B FI107700B (en) 2001-09-28

Family

ID=9415269

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940224A FI107700B (en) 1991-07-18 1994-01-17 Process for the preparation of ophthalmic compositions

Country Status (10)

Country Link
EP (1) EP0594770B1 (en)
AT (1) ATE147627T1 (en)
AU (1) AU2388392A (en)
DE (1) DE69216831T2 (en)
DK (1) DK0594770T3 (en)
ES (1) ES2099272T3 (en)
FI (1) FI107700B (en)
FR (1) FR2679135B1 (en)
NO (1) NO940160L (en)
WO (1) WO1993001814A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19511322C2 (en) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile eye gels containing medium chain triglycerides and process for their preparation
US6284269B1 (en) * 1997-08-27 2001-09-04 Hexal Ag Pharmaceutical compositions of meloxicam with improved solubility and bioavailability
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
WO1999059634A1 (en) * 1998-05-15 1999-11-25 Wakamoto Pharmaceutical Co., Ltd. Anti-inflammatory eye drops
WO2001037838A1 (en) * 1999-11-24 2001-05-31 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1649858A1 (en) * 2003-07-10 2006-04-26 Arturo Jimenez Bayardo Method of preparing an aqueous meloxicam solution and aqueous solution thus produced
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
EP2094236A1 (en) * 2006-12-22 2009-09-02 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Gel useful for the delivery of ophthalmic drugs
EP2488145B1 (en) 2009-10-12 2024-04-24 Boehringer Ingelheim Vetmedica GmbH Containers for compositions comprising meloxicam
BR112012022073A2 (en) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh use of meloxicam for the long-term treatment of musculoskeletal disorders in cats.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (en) * 1977-11-07 1985-12-11 東興薬品工業株式会社 eye drops
JPS5913714A (en) * 1982-07-13 1984-01-24 Taito Pfizer Kk Antiphlogistic and analgesic agent for external use

Also Published As

Publication number Publication date
DE69216831D1 (en) 1997-02-27
DE69216831T2 (en) 1997-07-31
ATE147627T1 (en) 1997-02-15
FR2679135B1 (en) 1995-05-19
FI940224A (en) 1994-03-14
FI107700B (en) 2001-09-28
EP0594770A1 (en) 1994-05-04
ES2099272T3 (en) 1997-05-16
AU2388392A (en) 1993-02-23
DK0594770T3 (en) 1997-07-21
WO1993001814A1 (en) 1993-02-04
NO940160L (en) 1994-03-04
FR2679135A1 (en) 1993-01-22
NO940160D0 (en) 1994-01-17
EP0594770B1 (en) 1997-01-15

Similar Documents

Publication Publication Date Title
FI940224A0 (en) Ophthalmic compositions containing oxycam or oxycam derivatives
DK0418339T3 (en) Preparation and Method for Preventing Tissues Between Body Tissues
BE847686A (en) OCULAR INSERTION BODY FOR THE TREATMENT OF EYE DRYCITIS BY AQUEOUS DEFICIENCY,
DK0495421T3 (en) Use of carrageenans in topical ophthalmic compositions
BR0015416A (en) Compositions containing tetraenoic hydroxyieic acid derivatives and methods of use in the treatment of dry eye disorders
KR880003616A (en) Wound healing
RU94046143A (en) Pharmaceutical composition for glaucoma treatment
DE69419640D1 (en) Pharmacological use of 5-aminophthaloylhydrazide; their composition and application
ES2132241T3 (en) OPHTHALMIC COMPOSITIONS AND METHODS FOR CONSERVATION AND USE.
SE8801710D0 (en) NEW OPHTALMOLOGICAL COMPOSITION OF MATTER
DE3676335D1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON MERCAPTOETHANESULPHONIC ACIDS, ORGANIC COMBATINGS OF MERCAPTOETHANESULPHONIC ACIDS AND METHOD FOR THE PRODUCTION THEREOF.
FI940081A (en) Polyacrylic-based compositions for eye inflammation
SE8704979D0 (en) NEW FURANURONIC ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE
AU538612B2 (en) Salt of furosemide or piretanide as acid component and penbutolol or (-)-3-(4-3-(3,4-dimethoxyphenylethylamino)-2- hydroxypropoxy)-phenyl)-crotonitrile as base component
NO940064L (en) Eye preparation on polyacrylic acid basis
ES2060103T3 (en) HYDROPHILIC AMPHOLYTE POLYMERS, THEIR PREPARATION PROCEDURE, AND THEIR USE AS ABSORBENT AGENTS.
FR2342972A2 (en) PURINE DERIVATIVES FOR USE AS MEDICINAL PRODUCTS FOR THE TREATMENT OF VIRAL INFECTIONS
MC2217A1 (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR OPTALMOLOGICAL USE CONTAINING HEXETIDINE OR ITS DERIVATIVES OR SALTS
IT1244615B (en) STERILIZING COMPOSITION
FR2442052A1 (en) Human glaucoma treatment with labetalol - which is an amino- and hydroxyalkyl substd. salicylamide
RU93015155A (en) MEDICINE FOR THE TREATMENT OF DYSTROPHIC DISEASES AND INJURIES OF THE EYE TISSUES
CA1273296C (en) Soluble collagen composition
TH58970B (en) Formula for use on eyes
RU93019277A (en) SOLUTION FOR THE PROTECTION AND TREATMENT OF DISEASES AND DAMAGE TO THE CORNICE VIZITON

Legal Events

Date Code Title Description
MA Patent expired